Literature DB >> 909613

Effects of pentoxifylline on red blood cell deformability and blood viscosity under hyperosmolar conditions.

H Leonhardt, H G Grigoleit.   

Abstract

Using a hyperosmolar erythrocyte model, the authors studied the effect of changes in red cell deformability on whole blood viscosity and investigated the possibility of using pentoxifylline to modify red cell deformability and whole blood viscosity. In vitro studies reveal a significant correlation between the two parameters in as much as they are inversely proportionate, i.e. viscosity increases as red cell deformability decreases and vice versa. Addition of pentoxyfylline improves impaired red cell deformability under hyperosmolar conditions and simultaneously produces a reduction in whole blood viscosity.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 909613     DOI: 10.1007/bf00498562

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  12 in total

1.  [Investigations on the Influence of Thrombocytes and Temperature on the Whole Blood- and Plasma-Viscosity as Comparative Measurements Between a Capillary- and a Plate-Cone-Viscosimeter (author's transl)].

Authors:  H Leonhardt; I Stelter
Journal:  Experientia       Date:  1975-10-15

2.  [Influencing the deformability of erythrocytes through pentoxiphyllin].

Authors:  A M Ehrly
Journal:  Med Welt       Date:  1975-12-19

3.  Influence of plasma hypertonicity on blood viscosity studies in vitro and in an isolated vascular bed.

Authors:  S N Rasmussen
Journal:  Acta Physiol Scand       Date:  1972-04

4.  Rheology of human foetal blood with reference to haematocrit, plasma viscosity, osmolality and pH.

Authors:  A Giombi; E D Burnard
Journal:  Biorheology       Date:  1970-04       Impact factor: 1.875

5.  Red cell deformation and fluidity of concentrated cell suspensions.

Authors:  R Wells; H Schmid-Schönbein
Journal:  J Appl Physiol       Date:  1969-08       Impact factor: 3.531

6.  Alteration of deformability of the erythrocyte membrane in stored blood.

Authors:  P L La Celle
Journal:  Transfusion       Date:  1969 Sep-Oct       Impact factor: 3.157

7.  Influence of plasma osmolarity on the rheology of human blood.

Authors:  H J Meiselman; E W Merrill; E R Gilliland; G A Pelletier; E W Salzman
Journal:  J Appl Physiol       Date:  1967-04       Impact factor: 3.531

8.  Microrheological effects of the vasoactive compound 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (pentoxifylline, BL 191).

Authors:  H G Grigoleit; G Jacobi
Journal:  Vasa       Date:  1977       Impact factor: 1.961

9.  Effect of pentoxifylline on energy rich phosphates in rat's erythrocytes.

Authors:  V Stefanovich
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1975-04

10.  Improvement of the flow properties of blood: a new therapeutical approach in occlusive arterial disease.

Authors:  A M Ehrly
Journal:  Angiology       Date:  1976-03       Impact factor: 3.619

View more
  10 in total

1.  Effect of pentoxifylline on single red cell deformability.

Authors:  D Seiffge; H Kiesewetter
Journal:  Klin Wochenschr       Date:  1981-11-16

2.  Effect of oxpentifylline on blood viscosity and cerebral blood flow in man.

Authors:  M M Brown
Journal:  Br J Clin Pharmacol       Date:  1989-10       Impact factor: 4.335

3.  Haemorheological parameters in patients with retinal artery occlusion and anterior ischaemic optic neuropathy.

Authors:  J Wiek; M Krause; M Schade; M Wiederholt; L L Hansen
Journal:  Br J Ophthalmol       Date:  1992-03       Impact factor: 4.638

4.  Removal of antineoplastic drugs cyclophosphamide, ifosfamide, and 5-fluorouracil and a vasodilator drug pentoxifylline from wastewaters by ozonation.

Authors:  Angela Yu-Chen Lin; Julia Han-Fang Hsueh; P K Andy Hong
Journal:  Environ Sci Pollut Res Int       Date:  2014-08-05       Impact factor: 4.223

Review 5.  Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy.

Authors:  A Ward; S P Clissold
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

6.  Cardioprotective actions of pentoxifylline in an animal model of acute myocardial ischaemia.

Authors:  W Gallenkämper; W Rücker; K Schrör
Journal:  Br J Pharmacol       Date:  1984-04       Impact factor: 8.739

7.  The effect of denbufylline on the viscosity of rat whole blood and on the deformability (filterability) of rat blood cell suspensions.

Authors:  J J Jukna; C D Nicholson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-04       Impact factor: 3.000

8.  Treatment of homozygous sickle cell disease with pentoxifylline.

Authors:  A Sacerdote
Journal:  J Natl Med Assoc       Date:  1999-08       Impact factor: 1.798

9.  Pentoxyphylline in association with vitamin E reduces cutaneous fibrosis in systemic sclerosis.

Authors:  Romy Beatriz Christmann de Souza; André Regis Macedo; Kátia Akemi Kuruma; Patricia Andrade Macedo; Claudia Teresa Lobato Borges
Journal:  Clin Rheumatol       Date:  2009-05-26       Impact factor: 2.980

Review 10.  Immunological mechanisms of pentoxifylline in chronic heart failure.

Authors:  Steven M Shaw; Mohammed K H Shah; Simon G Williams; James E Fildes
Journal:  Eur J Heart Fail       Date:  2009-02       Impact factor: 15.534

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.